-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ensomafusp Alfa in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ensomafusp Alfa in Marginal Zone B-cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ensomafusp Alfa in Marginal Zone B-cell Lymphoma Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lebrikizumab in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lebrikizumab in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lebrikizumab in Atopic Dermatitis (Atopic Eczema) Drug Details: Lebrikizumab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Crovalimab in Sickle Cell Disease With Vaso-Occlusive Crisis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Crovalimab in Sickle Cell Disease With Vaso-Occlusive Crisis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Crovalimab in Sickle Cell Disease With Vaso-Occlusive...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Crovalimab in Paroxysmal Nocturnal Hemoglobinuria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Crovalimab in Paroxysmal Nocturnal Hemoglobinuria report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Crovalimab in Paroxysmal Nocturnal Hemoglobinuria Drug Details: Crovalimab (Piasky) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TDM-180935 in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TDM-180935 in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TDM-180935 in Atopic Dermatitis (Atopic Eczema) Drug Details: TDM-180935...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IMPT-314 in Primary Mediastinal B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMPT-314 in Primary Mediastinal B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMPT-314 in Primary Mediastinal B-Cell Lymphoma Drug Details: IMPT-314...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BSI-060T in Thyroid Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BSI-060T in Thyroid Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BSI-060T in Thyroid Cancer Drug Details: BSI-060T is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AVA-6000 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AVA-6000 in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AVA-6000 in Esophageal Cancer Drug Details: AVA-6000 is under development for...
-
Product Insights
NewQuarterly Juices pricing trends in Saudi Arabia
Empower your strategies with our Quarterly Juices pricing trends in Saudi Arabia report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...